Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Dose-dependent effect of anti-CTLA-4 on survival in sepsis
Shigeaki Inoue
, Lulong Bo
, Jinjun Bian
, Jacqueline Unsinger
, Katherine Chang
,
Richard S. Hotchkiss
Institute of Clinical and Translational Sciences (ICTS)
COVID-19 Researchers
Bursky Center for Human Immunology and Immunotherapy
Division of Research
Research output
:
Contribution to journal
›
Article
›
peer-review
137
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Dose-dependent effect of anti-CTLA-4 on survival in sepsis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Sepsis
100%
Dose-dependent
100%
Cytotoxic T-lymphocyte-associated Protein 4 (CTLA-4)
100%
Anticytotoxic
100%
After Surgery
27%
Apoptosis
18%
Regulatory T Cells
18%
CD4-CD8 Ratio
18%
Spleen
18%
CD4 T Cells
18%
Cecal Ligation
18%
Cecal Puncture
18%
CD8 T Cells
18%
Adverse Effects
9%
T Cell Activation
9%
High Dose
9%
Immunosuppression
9%
Immune Suppression
9%
Costimulation
9%
In Cancer
9%
Sham
9%
CD28
9%
T Cell Proliferation
9%
Cytokine Production
9%
Apoptosis Induction
9%
Puncture Model
9%
Metastatic Cancer
9%
Sepsis Treatment
9%
Anti-inflammatory Cytokines
9%
Survival Study
9%
Immunity Boosting
9%
Immunity System
9%
Immune Defects
9%
Lethal Condition
9%
Immunology and Microbiology
CTLA-4
100%
Programmed Cell Death
30%
CD8
20%
Regulatory T Cell
20%
CD4
20%
T Cell Activation
10%
Low Drug Dose
10%
Drug Megadose
10%
Immunosuppression
10%
CD28
10%
Immunotherapy
10%
T Cell Proliferation
10%
Immunodeficiency
10%
Cytokine Production
10%
Inflammatory Cytokine
10%
Cytotoxic T Lymphocyte Antigen 4 Antibody
10%
Veterinary Science and Veterinary Medicine
CTLA-4
100%
Sepsis
100%
CD4
18%
Regulatory T Cell
18%
Cancer
18%
Mouse
9%
T Cell
9%
Metastatic Cancer
9%